| 标题 |
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:Enriqueta Felip; Byoung Chul Cho; V. Gutiérrez; Adlinda Alip; Benjamin Besse; et al 出版日期:2024-06-26 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)